Sig Brokerage LP Takes $763,000 Position in CME Group Inc. (NASDAQ:CME)

Sig Brokerage LP bought a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 3,285 shares of the financial services provider's stock, valued at approximately $763,000.

Several other large investors have also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in shares of CME Group by 1.0% in the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock worth $7,952,273,000 after buying an additional 326,623 shares during the period. Geode Capital Management LLC boosted its holdings in shares of CME Group by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock worth $1,946,717,000 after buying an additional 104,697 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after buying an additional 3,921,278 shares during the period. Norges Bank acquired a new position in shares of CME Group in the fourth quarter worth about $1,107,389,000. Finally, FIL Ltd boosted its holdings in shares of CME Group by 1.5% in the fourth quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock worth $947,821,000 after buying an additional 61,908 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

Insider Buying and Selling

In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now owns 27,046 shares in the company, valued at $6,774,211.62. The trade was a 12.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $273.17, for a total transaction of $81,951.00. Following the sale, the director now owns 24,767 shares in the company, valued at $6,765,601.39. This represents a 1.20% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 26,434 shares of company stock valued at $6,987,065. 0.30% of the stock is owned by company insiders.

CME Group Stock Performance

Shares of NASDAQ:CME traded up $1.65 during trading on Monday, reaching $277.94. The stock had a trading volume of 1,617,773 shares, compared to its average volume of 2,179,403. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $286.48. The firm has a market capitalization of $100.16 billion, a price-to-earnings ratio of 28.74, a P/E/G ratio of 6.76 and a beta of 0.45. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a fifty day simple moving average of $265.86 and a two-hundred day simple moving average of $247.33.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the firm posted $2.50 earnings per share. The company's quarterly revenue was up 10.4% compared to the same quarter last year. As a group, analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date is Monday, June 9th. CME Group's dividend payout ratio (DPR) is currently 50.30%.

Analysts Set New Price Targets

CME has been the subject of several research reports. Raymond James upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target for the company in a report on Monday, March 10th. Erste Group Bank upgraded shares of CME Group to a "strong-buy" rating in a report on Monday, March 17th. JPMorgan Chase & Co. decreased their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Piper Sandler raised their price target on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. Finally, Morgan Stanley raised their price target on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $256.80.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.